Blood cancers
Multiple myeloma patients missing out on optimal therapy
Australian multiple myeloma patients are failing to advance to subsequent lines of therapy and are therefore missing out on newer therapies, a registry study finds.
Presenting the findings at Blood 2019, Dr Jessie Zhao from Dorevitch Pathology, in Heidelberg, Melbourne, said...
Australian multiple myeloma patients are failing to advance to subsequent lines of therapy and are therefore missing out on newer...